Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2008

01-02-2008 | Hepatic and Pancreatic Tumors

Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study

Authors: Jensen C. C. Tan, MD, Natalie G. Coburn, MD, Nancy N. Baxter, MD, Alex Kiss, PhD, Calvin H. L. Law, MD

Published in: Annals of Surgical Oncology | Issue 2/2008

Login to get access

Abstract

Background

Cholangiocarcinoma (CCA) is associated with poor survival and therapeutic nihilism. To date, there has not been an examination of the surgical management of CCA at a population level.

Methods

Using the Surveillance, Epidemiology and End Results (SEER) database, we identified all patients with intrahepatic CCA diagnosed between 1988 and 2003. Tumors categorized as a single, unilobar lesion with no evidence of vascular invasion were defined as localized. It was then determined whether patients received cancer directed surgery (CDS). Multivariable logistic regression was used to evaluate factors associated with CDS in patients with localized disease. The influence of CDS on overall survival (OS) was evaluated using Kaplan–Meier curves and Cox proportional hazards modeling.

Results

Only 446 (12%) of 3,756 patients with intrahepatic CCA underwent CDS. On multivariable analysis, non-Klatskin tumor (p < 0.01) and younger age (p = 0.02) was associated with CDS. Localized disease was strongly associated with CDS (p < 0.01); however, only 91 (37%) of these 248 patients underwent CDS. Of patients with localized disease, those who had CDS had significantly better survival than those who did not (p < 0.01), with median overall survival (OS) of 44 months versus 8 months, and five-year OS of 42% versus 4%, respectively.

Conclusions

Patients with localized CCA who are selected for CDS are strongly associated with improved survival, with rates approaching that found in single institution studies. However, many patients with localized tumors do not receive potentially curative cancer-directed surgery. Further study is warranted to address the barriers to the delivery of appropriate care to these patients.
Appendix
Available only for authorised users
Literature
1.
2.
Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004;40:472–7PubMedCrossRef
3.
Patel T. Rising incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001;33:1353–7PubMedCrossRef
4.
Nakeeb A, Pitt HA, Taylor AS, Coleman J, Abrams RA, Piantadosi, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463–75
5.
De Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999;341:1368–78PubMedCrossRef
6.
Malhi H, Gores GJ. Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther 2006;23:1287–96PubMedCrossRef
7.
Kelley ST, Bloomston M, Serafini F, Carey LC, Karl RC, Zervos E, et al. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy. Am Surg 2004;70:743–9PubMed
8.
Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg 2005;241:693–702PubMedCrossRef
9.
Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB, et al. Transplantation for Hilar Cholangiocarcinoma. Liver Transpl 2004;10:S65–S68PubMedCrossRef
10.
Knox JJ, Hedley D, Oza A, Feld R, Siu LL, Chen E, et al. Combining gemcitabine and capecitabine in patients with advanced biliary Cancer: a Phase II trial. J Clin Oncol 2005;23:2332–8PubMedCrossRef
11.
Zervos EE, Osborne D, Goldin SB, Villadolid DV, Thometz DP, Durkin A, et al. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg 2005;109:810–5CrossRef
12.
Roayaie S, Guarrera JV, Ye MQ, Thung SN, Emre S, Fishbein TM, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 1998;187:365–72PubMedCrossRef
13.
Chu KM, Lai EC, Al-Hadeedi SA, Lo CE Jr, Liu CM, Fan CL, et al. Intrahepatic cholangiocarcinoma. World J Surg 1997;21:301–5PubMedCrossRef
14.
Cherqui D, Tantawi B, Alon R, Piedbois P, Rahmouni A, Dhumeaux D, et al. Intrahepatic cholangiocarcioma. Results of aggressive surgical management. Arch Surg 1995;130:1073–8PubMed
15.
Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995;130:270–6PubMed
16.
Lang H, Sotiropoulos GC, Fruhauf NR, Domland M, Andreas P, Kind E, et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 2005;241:134–43PubMed
17.
Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003;10:259–64PubMedCrossRef
18.
Neuhaus P, Jonas S, Settmacher U, Thelen A, Benckert C, Lopez-Hanninen, et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg 2003;388:194–200
19.
Jarnigin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz J, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507–17CrossRef
20.
Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451–8PubMed
21.
Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Surivival after hepatic resection for colorectal metastases: A 10-year experience. Ann Surg Oncol 2006;13:668–76PubMedCrossRef
22.
Chen MF, Jan YY, Wang CS, et al. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer 1989;64:2226–31PubMedCrossRef
23.
Schlinkert RT, Nagorney DM, Van Heerden JA, et al. Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment. HPB Surg 1992;5:95–101PubMedCrossRef
24.
O’Connell JB, Maggard MA, Ko CY. Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol 2004;11:962–9PubMedCrossRef
25.
Harrell F. Regression Modeling Strategies. Springer-Verlag, New York, 2002
26.
Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 2006;107:2143–51PubMedCrossRef
27.
Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurn J, Virnig BA. Lymph node valuation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 2005;97:219–25PubMedCrossRef
28.
Govindarajan A, Coburn NG, Kiss A, Rabeneck L, Smith AJ, Law CHL. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst 2006;98:1474–81PubMed
29.
Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 2006;244:602–10PubMed
30.
Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007;297:278–85PubMedCrossRef
31.
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41–55CrossRef
Metadata
Title
Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study
Authors
Jensen C. C. Tan, MD
Natalie G. Coburn, MD
Nancy N. Baxter, MD
Alex Kiss, PhD
Calvin H. L. Law, MD
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9627-x

Other articles of this Issue 2/2008

Annals of Surgical Oncology 2/2008 Go to the issue

Melanomas

The Complex Relationships Between Sentinel Node Positivity, Patient Age, and Primary Tumor Desmoplasia: Analysis of 2303 Melanoma Patients Treated at a Single Center

Gastrointestinal Oncology

Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Gastrointestinal Oncology

Safety and Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with High-Dose Oxaliplatin in Patients with Peritoneal Carcinomatosis

Gynecologic Oncology

Prognosis of Patients Who Relapse after Fertility-Sparing Surgery in Epithelial Ovarian Cancer

Gynecologic Oncology

Fluorescence in situ Hybridization and Immunohistochemical Analysis of p53 Expression in Endometrial Cancer: Prognostic Value and Relation to Ploidy

Endocrine Tumors

Laparoscopic Resection of Extraadrenal Pheochromocytoma